Informazioni
Non ci sono recensioni
Epidemiology and Risk Factors
Pages 1-9
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Adenocarcinoma of the Esophagogastric Junction
From Barrett's Esophagus to Cancer
Giacopuzzi, Zanoni, de Manzoni
Editore
Springer
Anno
2017
Pagine
280
ISBN
9783319287744
110,00 €
DA SCONTARE
This book offers up-to-date and comprehensive coverage of the diagnosis and therapy of adenocarcinoma of the esophagogastric junction (EGJ). As is appropriate in the era of multidisciplinary and multimodal treatment, the contributions of all the various specialists involved cooperatively in the treatment of EGJ cancer are thoroughly described. Detailed attention is also paid to the significance of preneoplastic lesions, such as Barrett esophagus. The final part of the book represents a surgical atlas documenting the techniques used in the EGJ region, with superb color images and stepwise description of procedures. Against the background of the rapidly increasing incidence in EGJ cancer, especially evident in Western countries, there is a need for greater uniformity in management strategies, which currently vary significantly across the world. This book provides appropriate guidance that will assist all practitioners involved in the diagnosis and treatment of EGJ cancers, including surgeons, oncologists, and radiotherapists.
-
-
Barrett’s Esophagus: Pathogenesis and Prevention
Pages 11-16
-
Surveillance in Barrett’s Esophagus and Dysplasia
Pages 17-23
-
Ablation Techniques for Barrett’s Esophagus and Dysplasia
Pages 25-34
-
Endoscopic Resection for Barrett’s Esophagus to Dysplasia
Pages 35-39
-
7th Edition AJCC/UICC Staging: Esophagus and Esophagogastric Junction
Pages 41-46
-
Siewert Classification of Adenocarcinoma of the Esophagogastric Junction: Still In or Already Out?
Pages 47-56
-
Preoperative Work-Up: Conventional Radiology, CT Scan, Ultrasonography, and MRI
Pages 57-65
-
Role of PET/CT and MRI in the Prediction of Response to Neoadjuvant Treatment
Pages 67-83
-
Molecular Markers in the Prediction of Response to Neoadjuvant Treatments in Esophagogastric Junction Adenocarcinoma
Pages 85-94
-
Pathological Response to Neoadjuvant Treatment: More Questions Than Answers
Pages 95-99
-
Hospital Volume and Centralization in EGJ Cancer
Pages 101-105
-
Patient Selection and Tailored Treatment Principles
Pages 107-116
-
How to Treat EGJ Cancer: Indications and Treatment Strategy
Pages 117-137
-
Chemotherapy in Oesophagogastric Junctional Cancer
Pages 139-148
-
Chemoradiation in Esophagogastric Junction Cancer
Pages 149-161
-
Signet Ring Carcinoma in EGJ: What Is It?
Pages 163-169
-
Morbid-Mortality and Treatment of Complications
Pages 171-184
-
Long-Term Results with Surgery Alone and Multimodal Treatments
Pages 185-191
-
Open or Minimally Invasive? Comparison of Early and Late Results
Pages 193-203
-
Enhanced Recovery After Surgery (ERAS) and Nutritional Aspects
Pages 205-216
-
Unresectable and Metastatic Cancer
Pages 217-224
-
Recurrence: Treatment or Just Palliation?
Pages 225-235
-
Follow-Up and Quality of Life
Pages 237-244
-
Surgical Anatomy of the Esophagus and Esophagogastric Junction
Pages 245-259
-
Surgical Technique: Open Procedures
Pages 261-270
-
Surgical Technique: Minimally Invasive Procedures
Pages 271-275
